Showing 1 - 20 results of 61 for search 'Tsung-Hui Hu', query time: 0.08s Refine Results
  1. 1
    Quantitative Assessment of Steatosis in Liver Tissue Using Controlled Attenuation Parameter

    Quantitative Assessment of Steatosis in Liver Tissue Using Controlled Attenuation Parameter by Cheng-Kun Wu, Tsung-Hui Hu

    Published 2014-09-01
    Get full text
    Article
  2. 2
    Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.

    Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes. by Ching-Jung Hsieh, Pei Wen Wang, Tsung Hui Hu

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement

    Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement by Siew Tzuh Tang, Chung-Chi Huang, Tsung-Hui Hu, Wen-Chi Chou, Li-Pang Chuang, Ming Chu Chiang

    Published 2021-08-01
    Get full text
    Article
  4. 4
    Liver stiffness measurement in cirrhotic patient — Implications of disease activity and treatment efficacy

    Liver stiffness measurement in cirrhotic patient — Implications of disease activity and treatment efficacy by Huang-Wei Xu, Sheng-Nan Lu, Chao-Hung Hung, Kuo-Chin Chang, Tsung-Hui Hu, Jing-Houng Wang

    Published 2012-12-01
    Get full text
    Article
  5. 5
    The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals.

    The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals. by Yu-Chi Lee, Tsung-Hui Hu, Chao-Hung Hung, Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang

    Published 2019-01-01
    Get full text
    Article
  6. 6
    Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C

    Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C by Chao-Hung Hung, Tsung-Hui Hu, Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, Chuan-Mo Lee

    Published 2016-04-01
    Get full text
    Article
  7. 7
    Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment.

    Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment. by Te-Ling Ma, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung Chen

    Published 2019-01-01
    Get full text
    Article
  8. 8
    Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data.

    Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data. by Yi-Hao Yen, Chien-Hung Chen, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Kwong-Ming Kee, Tsung-Hui Hu

    Published 2019-01-01
    Get full text
    Article
  9. 9
    Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection

    Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection by Ming-Chao Tsai, Yi-Hao Yen, Kuo-Chin Chang, Chao-Hung Hung, Chien-Hung Chen, Ming-Tsung Lin, Tsung-Hui Hu

    Published 2019-12-01
    Get full text
    Article
  10. 10
    Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse

    Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse by Tzu-Ning Tseng, Yuan-Hung Kuo, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung Chen

    Published 2022-05-01
    Get full text
    Article
  11. 11
    ICU bereaved surrogates’ comorbid psychological-distress states and their associations with prolonged grief disorder

    ICU bereaved surrogates’ comorbid psychological-distress states and their associations with prolonged grief disorder by Fur-Hsing Wen, Wen-Chi Chou, Chung-Chi Huang, Tsung-Hui Hu, Ming Chu Chiang, Li-Pang Chuang, Siew Tzuh Tang

    Published 2022-04-01
    Get full text
    Article
  12. 12
    Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice.

    Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-Worl... by Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, Po-Lin Tseng, Kuo-Chin Chang, Cheng-Kun Wu, Tsung-Hui Hu

    Published 2016-01-01
    Get full text
    Article
  13. 13
    Liver stiffness measurement at complete virological response in hepatoma prediction for HBV‐related cirrhosis patient with potent antiviral agent

    Liver stiffness measurement at complete virological response in hepatoma prediction for HBV‐related cirrhosis patient with potent antiviral agent by Jing‐Houng Wang, Tsung‐Hui Hu, Chien‐Hung Chen, Chao‐Hung Hung, Yi‐Hao Yen, Kuo‐Chin Chang, Sheng‐Nan Lu

    Published 2019-11-01
    Get full text
    Article
  14. 14
    Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy

    Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy by Kuo-Chin Chang, Yi-Hao Ye, Cheng-Kun Wu, Ming-Tsung Lin, Ming-Chao Tsai, Po-Lin Tseng, Tsung-Hui Hu

    Published 2018-11-01
    Get full text
    Article
  15. 15
    Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C.

    Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C. by Yi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung

    Published 2019-01-01
    Get full text
    Article
  16. 16
    Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

    Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL by Chih-Chien Yao, Chao-Hung Hung, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Hung Wang, Chung-Mo Lee, Chien-Hung Chen

    Published 2017-05-01
    Get full text
    Article
  17. 17
    Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy

    Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy by Hsin-Wei Fang, Po-Lin Tseng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu, Chien-Hung Chen

    Published 2024-04-01
    Get full text
    Article
  18. 18
    HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral

    HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral by Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu

    Published 2022-11-01
    Get full text
    Article
  19. 19
    Significance of Vitamin D Receptor Gene Polymorphisms for Risk of Hepatocellular Carcinoma in Chronic Hepatitis C

    Significance of Vitamin D Receptor Gene Polymorphisms for Risk of Hepatocellular Carcinoma in Chronic Hepatitis C by Chao-Hung Hung, Yi-Chun Chiu, Tsung-Hui Hu, Chien-Hung Chen, Sheng-Nan Lu, Chao-Min Huang, Jing-Houng Wang, Chuan-Mo Lee

    Published 2014-08-01
    Get full text
    Article
  20. 20
    Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation

    Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation by Shih-Yu Yang, Tsung-Hui Hu, Yeh-Pin Chou, Yuan-Hung Kuo, Ming-Chao Tsai, Kuo-Chin Chang, Yi-Hao Yen, Po-Lin Tseng

    Published 2023-11-01
    Get full text
    Article

Search Tools: